Bruce L. Levine

Publications

• B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Re-expansion in a Patient with Myeloma Following Salvage Programmed Cell Death Protein 1 Inhibitor-based Combination Therapy
  British Journal of Haematology. Mar, 2021  |   Pubmed ID: 33713436
• CCR5-edited CD4 T Cells Augment HIV-specific Immunity to Enable Post Rebound Control of HIV Replication
  The Journal of Clinical Investigation. Feb, 2021  |   Pubmed ID: 33571163
• Author Correction: Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia
  Nature Medicine. Feb, 2021  |   Pubmed ID: 33547459
• The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?
  Stem Cells and Development. 02, 2021  |   Pubmed ID: 33307968
• Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 02, 2021  |   Pubmed ID: 33186691
• Diagnostic Biomarkers to Differentiate Sepsis from Cytokine Release Syndrome in Critically Ill Children
  Blood Advances. 10, 2020  |   Pubmed ID: 33095872
• Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 11, 2020  |   Pubmed ID: 32730744
• Emerging Trends in COVID-19 Treatment: Learning from Inflammatory Conditions Associated with Cellular Therapies
  Cytotherapy. 09, 2020  |   Pubmed ID: 32565132
• International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy Statement on Extracellular Vesicles from Mesenchymal Stromal Cells and Other Cells: Considerations for Potential Therapeutic Agents to Suppress Coronavirus Disease-19
  Cytotherapy. 09, 2020  |   Pubmed ID: 32425691
• Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 09, 2020  |   Pubmed ID: 32298202
• Accelerating the Development of Innovative Cellular Therapy Products for the Treatment of Cancer
  Cytotherapy. 05, 2020  |   Pubmed ID: 32199724
• CRISPR-engineered T Cells in Patients with Refractory Cancer
  Science (New York, N.Y.). 02, 2020  |   Pubmed ID: 32029687
• The Long Road to the First FDA-approved Gene Therapy: Chimeric Antigen Receptor T Cells Targeting CD19
  Cytotherapy. 02, 2020  |   Pubmed ID: 32014447
• CAR T-cell Product Performance in Haematological Malignancies Before and After Marketing Authorisation
  The Lancet. Oncology. 02, 2020  |   Pubmed ID: 32007196
• CD19-targeting CAR T Cell Immunotherapy Outcomes Correlate with Genomic Modification by Vector Integration
  The Journal of Clinical Investigation. 02, 2020  |   Pubmed ID: 31845905
• Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 02, 2020  |   Pubmed ID: 31815579
• Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies
  Methods in Molecular Biology (Clifton, N.J.). 2020  |   Pubmed ID: 31707678
• T-cell Phenotypes Associated with Effective CAR T-cell Therapy in Postinduction Vs Relapsed Multiple Myeloma
  Blood Advances. 10, 2019  |   Pubmed ID: 31575532
• CAR T Cell Viability Release Testing and Clinical Outcomes: is There a Lower Limit?
  Blood. 11, 2019  |   Pubmed ID: 31554634
• A Multiscale Simulation Framework for the Manufacturing Facility and Supply Chain of Autologous Cell Therapies
  Cytotherapy. 10, 2019  |   Pubmed ID: 31445816
• Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 11, 2019  |   Pubmed ID: 31420241
• B Cell Maturation Antigen-specific CAR T Cells Are Clinically Active in Multiple Myeloma
  The Journal of Clinical Investigation. 03, 2019  |   Pubmed ID: 30896447
• Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells
  CPT: Pharmacometrics & Systems Pharmacology. 05, 2019  |   Pubmed ID: 30848084
• Chimeric Antigen Receptor-T Cell Therapy Manufacturing: Modelling the Effect of Offshore Production on Aggregate Cost of Goods
  Cytotherapy. 02, 2019  |   Pubmed ID: 30770285
• Powered and Controlled T-cell Production
  Nature Biomedical Engineering. 03, 2018  |   Pubmed ID: 31015722
• CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
  Frontiers in Immunology. 2018  |   Pubmed ID: 30559740
• Induction of Resistance to Chimeric Antigen Receptor T Cell Therapy by Transduction of a Single Leukemic B Cell
  Nature Medicine. 10, 2018  |   Pubmed ID: 30275568
• Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 12, 2018  |   Pubmed ID: 30190371
• Reducing Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
  Cancer Immunology Research. 09, 2018  |   Pubmed ID: 30030295
• Nonviral RNA Chimeric Antigen Receptor-modified T Cells in Patients with Hodgkin Lymphoma
  Blood. 09, 2018  |   Pubmed ID: 29925499
• Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-targeted T Cells
  Nature. 06, 2018  |   Pubmed ID: 29849141
• Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia
  Nature Medicine. 05, 2018  |   Pubmed ID: 29713085
• Anti-CD19 CAR T Cells with High-dose Melphalan and Autologous Stem Cell Transplantation for Refractory Multiple Myeloma
  JCI Insight. 04, 2018  |   Pubmed ID: 29669947
• Personalized Cancer Vaccine Effectively Mobilizes Antitumor T Cell Immunity in Ovarian Cancer
  Science Translational Medicine. 04, 2018  |   Pubmed ID: 29643231
• Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
  Gastroenterology. 07, 2018  |   Pubmed ID: 29567081
• Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
  The New England Journal of Medicine. 02, 2018  |   Pubmed ID: 29385370
• Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 01, 2018  |   Pubmed ID: 29203150
• Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
  The New England Journal of Medicine. 12, 2017  |   Pubmed ID: 29226764
• Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
  Cancer Immunology Research. 12, 2017  |   Pubmed ID: 29109077
• Exploring Synthetic Immunity: From Boutique to Global
  Human Vaccines & Immunotherapeutics. 10, 2017  |   Pubmed ID: 28945504
• Cellular Kinetics of CTL019 in Relapsed/refractory B-cell Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia
  Blood. 11, 2017  |   Pubmed ID: 28935694
• Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy
  Current Hematologic Malignancy Reports. 08, 2017  |   Pubmed ID: 28762038
• A Single Dose of Peripherally Infused EGFRvIII-directed CAR T Cells Mediates Antigen Loss and Induces Adaptive Resistance in Patients with Recurrent Glioblastoma
  Science Translational Medicine. 07, 2017  |   Pubmed ID: 28724573
• Monocyte Lineage-derived IL-6 Does Not Affect Chimeric Antigen Receptor T-cell Function
  Cytotherapy. 07, 2017  |   Pubmed ID: 28506444
• Global Manufacturing of CAR T Cell Therapy
  Molecular Therapy. Methods & Clinical Development. Mar, 2017  |   Pubmed ID: 28344995
• Showcasing Clinical Development and Production of Cellular Therapies
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 04, 2017  |   Pubmed ID: 28341560
• PD-1 Blockade Modulates Chimeric Antigen Receptor (CAR)-modified T Cells: Refueling the CAR
  Blood. 02, 2017  |   Pubmed ID: 28031179
• Optimization of CGMP Purification and Expansion of Umbilical Cord Blood-derived T-regulatory Cells in Support of First-in-human Clinical Trials
  Cytotherapy. 02, 2017  |   Pubmed ID: 27887864
• Engineered T Cells: the Promise and Challenges of Cancer Immunotherapy
  Nature Reviews. Cancer. 08, 2016  |   Pubmed ID: 27550819
• MiR-146b Antagomir-treated Human Tregs Acquire Increased GVHD Inhibitory Potency
  Blood. 09, 2016  |   Pubmed ID: 27485827
• Novel Gene and Cellular Therapy Approaches for Treating HIV
  Discovery Medicine. 04, 2016  |   Pubmed ID: 27232514
• Identification of Predictive Biomarkers for Cytokine Release Syndrome After Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
  Cancer Discovery. 06, 2016  |   Pubmed ID: 27076371
• Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist
  The Oncologist. 05, 2016  |   Pubmed ID: 27009942
• Infusion of CD3/CD28 Costimulated Umbilical Cord Blood T Cells at the Time of Single Umbilical Cord Blood Transplantation May Enhance Engraftment
  American Journal of Hematology. May, 2016  |   Pubmed ID: 26858124
• Smart CARS: Optimized Development of a Chimeric Antigen Receptor (CAR) T Cell Targeting Epidermal Growth Factor Receptor Variant III (EGFRvIII) for Glioblastoma
  Annals of Translational Medicine. Jan, 2016  |   Pubmed ID: 26855949
• Ibrutinib Enhances Chimeric Antigen Receptor T-cell Engraftment and Efficacy in Leukemia
  Blood. Mar, 2016  |   Pubmed ID: 26813675
• Phase I Study of Multi-gene Cell Therapy in Patients with Peripheral Artery Disease
  Vascular Medicine (London, England). Feb, 2016  |   Pubmed ID: 26584888
• Umbilical Cord Blood-derived T Regulatory Cells to Prevent GVHD: Kinetics, Toxicity Profile, and Clinical Effect
  Blood. Feb, 2016  |   Pubmed ID: 26563133
• T Cell Engineering As Therapy for Cancer and HIV: Our Synthetic Future
  Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. Oct, 2015  |   Pubmed ID: 26416683
• Chimeric Antigen Receptor T Cells Against CD19 for Multiple Myeloma
  The New England Journal of Medicine. Sep, 2015  |   Pubmed ID: 26352815
• Chimeric Antigen Receptor T Cells Persist and Induce Sustained Remissions in Relapsed Refractory Chronic Lymphocytic Leukemia
  Science Translational Medicine. Sep, 2015  |   Pubmed ID: 26333935
• NY-ESO-1-specific TCR-engineered T Cells Mediate Sustained Antigen-specific Antitumor Effects in Myeloma
  Nature Medicine. Aug, 2015  |   Pubmed ID: 26193344
• High-Dose Sirolimus and Immune-Selective Pentostatin Plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2015  |   Pubmed ID: 26071480
• The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2015  |   Pubmed ID: 25712684
• Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
  The New England Journal of Medicine. Oct, 2014  |   Pubmed ID: 25317870
• Engineered T Cells for Cancer Therapy
  Cancer Immunology, Immunotherapy : CII. Sep, 2014  |   Pubmed ID: 24943274
• Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
  The New England Journal of Medicine. Mar, 2014  |   Pubmed ID: 24597865
• Mesothelin-specific Chimeric Antigen Receptor MRNA-engineered T Cells Induce Anti-tumor Activity in Solid Malignancies
  Cancer Immunology Research. Feb, 2014  |   Pubmed ID: 24579088
• Combination Immunotherapy After ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-primed and Costimulated Autologous T Cells
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2014  |   Pubmed ID: 24520093
• Adoptive Immunotherapy for Cancer or Viruses
  Annual Review of Immunology. 2014  |   Pubmed ID: 24423116
• T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
  Cancer Immunology Research. Jul, 2013  |   Pubmed ID: 24777247
• T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
  Cancer Immunology Research. Jul, 2013  |   Pubmed ID: 24432303
• Identification of a Titin-derived HLA-A1-presented Peptide As a Cross-reactive Target for Engineered MAGE A3-directed T Cells
  Science Translational Medicine. Aug, 2013  |   Pubmed ID: 23926201
• A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: from Bench to Bedside
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2013  |   Pubmed ID: 23838316
• Cardiovascular Toxicity and Titin Cross-reactivity of Affinity-enhanced T Cells in Myeloma and Melanoma
  Blood. Aug, 2013  |   Pubmed ID: 23770775
• Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-intensity Conditioned Allogeneic Stem Cell Transplantation
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2013  |   Pubmed ID: 23635453
• Innovation and Opportunity for Chimeric Antigen Receptor Targeted T cells
  Cytotherapy. Sep, 2013  |   Pubmed ID: 23562306
• Chimeric Antigen Receptor-modified T Cells for Acute Lymphoid Leukemia
  The New England Journal of Medicine. Apr, 2013  |   Pubmed ID: 23527958
• Autologous Lysate-pulsed Dendritic Cell Vaccination Followed by Adoptive Transfer of Vaccine-primed Ex Vivo Co-stimulated T Cells in Recurrent Ovarian Cancer
  Oncoimmunology. Jan, 2013  |   Pubmed ID: 23482679
• Phase 2 Clinical Trial of Rapamycin-resistant Donor CD4+ Th2/Th1 (T-Rapa) Cells After Low-intensity Allogeneic Hematopoietic Cell Transplantation
  Blood. Apr, 2013  |   Pubmed ID: 23426943
• Efficient Clinical Scale Gene Modification Via Zinc Finger Nuclease-targeted Disruption of the HIV Co-receptor CCR5
  Human Gene Therapy. Mar, 2013  |   Pubmed ID: 23360514
• Antiviral Effects of Autologous CD4 T Cells Genetically Modified with a Conditionally Replicating Lentiviral Vector Expressing Long Antisense to HIV
  Blood. Feb, 2013  |   Pubmed ID: 23264589
• Convergence of Gene and Cell Therapy
  Regenerative Medicine. Nov, 2012  |   Pubmed ID: 23210811
• Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 12, 2012  |   Pubmed ID: 23092876
• Decade-long Safety and Function of Retroviral-modified Chimeric Antigen Receptor T Cells
  Science Translational Medicine. May, 2012  |   Pubmed ID: 22553251
• Costimulated Tumor-infiltrating Lymphocytes Are a Feasible and Safe Alternative Donor Cell Therapy for Relapse After Allogeneic Stem Cell Transplantation
  Blood. Mar, 2012  |   Pubmed ID: 22289893
• Phase I/II Randomized Trial of Dendritic Cell Vaccination with or Without Cyclophosphamide for Consolidation Therapy of Advanced Ovarian Cancer in First or Second Remission
  Cancer Immunology, Immunotherapy : CII. May, 2012  |   Pubmed ID: 22021066
• The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
  Science Translational Medicine. Nov, 2011  |   Pubmed ID: 22133721
• Optimizing Parameters for Clinical-scale Production of High IL-12 Secreting Dendritic Cells Pulsed with Oxidized Whole Tumor Cell Lysate
  Journal of Translational Medicine. Nov, 2011  |   Pubmed ID: 22082029
• Phase I Trial of Adoptive Cell Transfer with Mixed-profile Type-I/type-II Allogeneic T Cells for Metastatic Breast Cancer
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2011  |   Pubmed ID: 21948234
• T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
  Science Translational Medicine. Aug, 2011  |   Pubmed ID: 21832238
• Chimeric Antigen Receptor-modified T Cells in Chronic Lymphoid Leukemia
  The New England Journal of Medicine. Aug, 2011  |   Pubmed ID: 21830940
• Engineered Artificial Antigen Presenting Cells Facilitate Direct and Efficient Expansion of Tumor Infiltrating Lymphocytes
  Journal of Translational Medicine. Aug, 2011  |   Pubmed ID: 21827675
• Massive Ex Vivo Expansion of Human Natural Regulatory T Cells (T(regs)) with Minimal Loss of in Vivo Functional Activity
  Science Translational Medicine. May, 2011  |   Pubmed ID: 21593401
• Combination Immunotherapy Using Adoptive T-cell Transfer and Tumor Antigen Vaccination on the Basis of HTERT and Survivin After ASCT for Myeloma
  Blood. Jan, 2011  |   Pubmed ID: 21030558
• Infusion of Ex Vivo Expanded T Regulatory Cells in Adults Transplanted with Umbilical Cord Blood: Safety Profile and Detection Kinetics
  Blood. Jan, 2011  |   Pubmed ID: 20952687
• Transfer of Influenza Vaccine-primed Costimulated Autologous T Cells After Stem Cell Transplantation for Multiple Myeloma Leads to Reconstitution of Influenza Immunity: Results of a Randomized Clinical Trial
  Blood. Jan, 2011  |   Pubmed ID: 20864577
• Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
  Cancer Research. Nov, 2010  |   Pubmed ID: 20926399
• Program Death-1 Signaling and Regulatory T Cells Collaborate to Resist the Function of Adoptively Transferred Cytotoxic T Lymphocytes in Advanced Acute Myeloid Leukemia
  Blood. Oct, 2010  |   Pubmed ID: 20570856
• Rapamycin Generates Anti-apoptotic Human Th1/Tc1 Cells Via Autophagy for Induction of Xenogeneic GVHD
  Autophagy. May, 2010  |   Pubmed ID: 20404486
• 4-1BB and CD28 Signaling Plays a Synergistic Role in Redirecting Umbilical Cord Blood T Cells Against B-cell Malignancies
  Human Gene Therapy. Jan, 2010  |   Pubmed ID: 19719389
• Efficient Clinical-scale Enrichment of Lymphocytes for Use in Adoptive Immunotherapy Using a Modified Counterflow Centrifugal Elutriation Program
  Cytotherapy. 2009  |   Pubmed ID: 19903104
• Depletion of Endogenous Tumor-associated Regulatory T Cells Improves the Efficacy of Adoptive Cytotoxic T-cell Immunotherapy in Murine Acute Myeloid Leukemia
  Blood. Oct, 2009  |   Pubmed ID: 19724059
• Rapid Immune Recovery and Graft-versus-host Disease-like Engraftment Syndrome Following Adoptive Transfer of Costimulated Autologous T Cells
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2009  |   Pubmed ID: 19509133
• Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells
  Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2009  |   Pubmed ID: 19259065
• Adoptive Immunotherapy: Good Habits Instilled at Youth Have Long-term Benefits
  Immunologic Research. 2008  |   Pubmed ID: 18949448
• CD28 Costimulation is Essential for Human T Regulatory Expansion and Function
  Journal of Immunology (Baltimore, Md. : 1950). Aug, 2008  |   Pubmed ID: 18684977
• A More Precise HIV Integration Assay Designed to Detect Small Differences Finds Lower Levels of Integrated DNA in HAART Treated Patients
  Virology. Sep, 2008  |   Pubmed ID: 18649912
• T Lymphocyte Engineering Ex Vivo for Cancer and Infectious Disease
  Expert Opinion on Biological Therapy. Apr, 2008  |   Pubmed ID: 18352851
• Identification and in Vitro Expansion of Functional Antigen-specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection
  Journal of Virology. May, 2008  |   Pubmed ID: 18337568
• Sleeping Beauty Transposon-mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies
  Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2008  |   Pubmed ID: 18227839
• Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating Stem Cell Differentiation
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2007  |   Pubmed ID: 17889349
• CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival
  Blood. Jun, 2007  |   Pubmed ID: 17311991
• Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion
  Cancer Research. Feb, 2007  |   Pubmed ID: 17293384
• Gene Transfer in Humans Using a Conditionally Replicating Lentiviral Vector
  Proceedings of the National Academy of Sciences of the United States of America. Nov, 2006  |   Pubmed ID: 17090675
• Stable Gene Transfer and Expression in Human Primary T Cells by the Sleeping Beauty Transposon System
  Blood. Jan, 2006  |   Pubmed ID: 16189271
• Adoptive Transfer of Costimulated T Cells Induces Lymphocytosis in Patients with Relapsed/refractory Non-Hodgkin Lymphoma Following CD34+-selected Hematopoietic Cell Transplantation
  Blood. Sep, 2003  |   Pubmed ID: 12763934
• TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-stage Ovarian Cancer Patients
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2003  |   Pubmed ID: 12684428
• Adoptive Transfer of Costimulated CD4+ T Cells Induces Expansion of Peripheral T Cells and Decreased CCR5 Expression in HIV Infection
  Nature Medicine. Jan, 2002  |   Pubmed ID: 11786906